Literature DB >> 9924298

Ocular contact time of a carbomer gel (GelTears) in humans.

C G Wilson1, Y P Zhu, M Frier, L S Rao, P Gilchrist, A C Perkins.   

Abstract

BACKGROUND/AIMS: Carbomers are widely used in products for the treatment of dry eye; however, the polymer gel thins on addition of probes (for example, fluorescein salt) confounding the comparison of products by objective clinical tests such as spectrophotofluorimetry or scintigraphy. A novel method of radiolabelling carbomer gels, with minimum change to their rheology, has permitted the non-invasive evaluation of precorneal residence of the gel in volunteers using gamma scintigraphy. The technique was used to evaluate the precorneal clearance of the liquid phase and of a suspended particulate in GelTears.
METHODS: Low sodium technetium-99m labelled diethylenetriaminepentacetic acid (99mTc-DTPA) was used to label carbomer 940 gel, either adsorbed onto sterile charcoal to model an entrapped drug, or added directly to the gel to a final activity of 1 MBq per 25 microliters dose. The clearance of the labelled gels was then compared with 99mTc-DTPA labelled saline in 12 volunteers.
RESULTS: The addition of the low sodium radiopharmaceutical produced insignificant rheological changes in the gel compared with conventional 99mTc-DTPA labelling. The residence times on the eye of the gel formulations were significantly greater than that of the saline control. At 8 minutes postdosing, the label levels retained (mean (SD)) on the ocular surface were: saline, 7% (7%); 99mTc-DTPA gel, 42% (27%); and 99mTc-carbon gel, 42% (20%) of administered dose. There was no difference observed in the precorneal distribution between 99mTc-DTPA solution and particulate markers.
CONCLUSIONS: These data demonstrate that carbomer based gels significantly extend contact of solutes or suspended solids with the corneal surface. The method of labelling does not significantly change the initial viscosity and is superior to previous methods which have used sodium salts (for example, sodium fluorescein) and therefore underestimate contact time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924298      PMCID: PMC1722369          DOI: 10.1136/bjo.82.10.1131

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.

Authors:  J L Greaves; C G Wilson; N R Galloway; A T Birmingham; O Olejnik
Journal:  Acta Ophthalmol (Copenh)       Date:  1991-08

2.  Formulation of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of simulated lacrimal fluid on their physico-chemical properties.

Authors:  N Unlü; A Ludwig; M van Ooteghem; A A Hincal
Journal:  Pharmazie       Date:  1991-11       Impact factor: 1.267

3.  [Corneal contact time of artificial tear solutions].

Authors:  R Marquardt; T Christ
Journal:  Klin Monbl Augenheilkd       Date:  1986-09       Impact factor: 0.700

4.  Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.

Authors:  G R Snibson; J L Greaves; N D Soper; J I Prydal; C G Wilson; A J Bron
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

  4 in total
  14 in total

Review 1.  Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.

Authors:  I Bravo-Osuna; V Andrés-Guerrero; P Pastoriza Abal; I T Molina-Martínez; R Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.

Authors:  Mona Hassan Aburahma; Azza Ahmed Mahmoud
Journal:  AAPS PharmSciTech       Date:  2011-10-07       Impact factor: 3.246

3.  Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid.

Authors:  Sunil Vooturi; David Bourne; Jiban Jyoti Panda; Stephanie Choi; Hyewon Kim; Sarath K Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2020-07-14       Impact factor: 2.850

4.  A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes.

Authors:  Qing Xiao; Yanhua Hu; Fei Chen; Xiaomin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

5.  Ocular films versus film-forming liquid systems for enhanced ocular drug delivery.

Authors:  Hamdia G Wafa; Ebtessam A Essa; Alaa E El-Sisi; Gamal M El Maghraby
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

6.  Treatment of chronic dry eye: focus on cyclosporine.

Authors:  George D Kymionis; Dimitrios I Bouzoukis; Vassilios F Diakonis; Charalambos Siganos
Journal:  Clin Ophthalmol       Date:  2008-12

7.  Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.

Authors:  Juçara Ribeiro Franca; Giselle Foureaux; Leonardo Lima Fuscaldi; Tatiana Gomes Ribeiro; Lívia Bomfim Rodrigues; Renata Bravo; Rachel Oliveira Castilho; Maria Irene Yoshida; Valbert Nascimento Cardoso; Simone Odília Fernandes; Sebastião Cronemberger; Anderson José Ferreira; André Augusto Gomes Faraco
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

8.  Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease.

Authors:  Klemens Fondi; Piotr A Wozniak; Doreen Schmidl; Ahmed M Bata; Katarzyna J Witkowska; Alina Popa-Cherecheanu; Leopold Schmetterer; Gerhard Garhöfer
Journal:  J Ophthalmol       Date:  2018-08-01       Impact factor: 1.909

9.  Comparison of the Safety and Efficacy between Preserved and Preservative-Free Latanoprost and Preservative-Free Tafluprost.

Authors:  Joon Mo Kim; Sang Woo Park; Mincheol Seong; Seung Joo Ha; Ji Woong Lee; Seungsoo Rho; Chong Eun Lee; Kyoung Nam Kim; Tae-Woo Kim; Kyung Rim Sung; Chan Yun Kim
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24

10.  Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

Authors:  Tong Lin; Lan Gong; Xing-Huai Sun; Nai-Qing Zhao; Wei Chen; Hui-Ping Yuan; Yan Shao; Ming-Hong Gao; Hai Tang
Journal:  Drug Des Devel Ther       Date:  2013-04-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.